ArticleJournal of assisted reproduction and genetics2025
The obstetrical and infant outcomes of trophectoderm biopsy on preimplantation genetic testing embryos after frozen single embryo transfer cycles.
Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Studying the Safety of Trophectoderm Biopsy Using Visible Femtosecond Laser Pulses.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeTo investigate if trophectoderm (TE) biopsy on preimplantation genetic testing (PGT) increases the risk of obstetrical and infant outcomes after frozen single blastocyst transfer cycles.
methodsThis retrospective cohort study included all frozen single blastocyst transfer cycles conducted between January 2012 and December 2017 at Peking University Third Hospital. A total of 1492 patients in the PGT group and 600 patients in the non-PGT group were analyzed. The primary outcomes were clinical pregnancy rate, live birth rate, and early motor development milestones. Secondary outcomes included miscarriage, obstetric complications, and infant outcomes.
resultsThe PGT group had younger parental ages and higher antral follicle counts, whereas the non-PGT group had lower sperm quality. The clinical pregnancy rate (52.7 vs. 45.2%, p = 0.002) and live birth rate (44.0 vs. 32.8%, p < 0.001) were significantly higher in the PGT group, while the miscarriage rate (13.6 vs. 22.5%, p < 0.001) was lower. In terms of early motor development, infants in the PGT group achieved milestones such as independent sitting, hand and knee crawling, and standing earlier (p < 0.001), although the timing of independent walking did not significantly differ between groups (p = 0.304). No significant differences were found between the two groups regarding pregnancy complications, infant outcomes, or early motor development. These findings were further confirmed through adjusted analyses.
conclusionPGT was associated with higher live birth rate and lower miscarriage rate in first single blastocyst transfer cycles. Blastocyst biopsy may not increase the risk of pregnancy complications or negatively impact early motor development in infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.